Skip to main content
Clinical Trials/NCT06099717
NCT06099717
Recruiting
N/A

Clinical Performance of a Novel Implant-supported Fixed Dental Prostheses (iFDP): the Dual-cantilevered Single-implant Bridge (T-bridge)

University of Bern1 site in 1 country50 target enrollmentJune 30, 2024

Overview

Phase
N/A
Intervention
Dual-cantilevered implant bridge
Conditions
Dental Implant Failed
Sponsor
University of Bern
Enrollment
50
Locations
1
Primary Endpoint
Implant and prosthetic success
Status
Recruiting
Last Updated
2 months ago

Overview

Brief Summary

The study aims to evaluate the clinical performance (implant and prosthetic survival/ success rates) of a novel implant-supported fixed dental prosthesis design: the dual-cantilevered single implant bridge (T-Bridge) made out of monolithic zirconia bonded to a titanium base abutment (Variobase abutments)

Registry
clinicaltrials.gov
Start Date
June 30, 2024
End Date
October 1, 2026
Last Updated
2 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 20 years
  • Willingness to sign an informed consent and participate in the study
  • Three missing adjacent teeth in the posterior site.
  • Tooth gap of 21-24 mm.
  • Presence of natural or artificial opposing dentition
  • Sufficient vertical interocclusal space of an implant restoration (7mm)
  • Sufficient ridge height to place an implant of 10mm in length
  • Sufficient ridge width for the placement of a 4.1mm diameter implant. Simultaneous GBR to achieve a width of 6.5mm will be included.

Exclusion Criteria

  • Any physical or mental disorder that would interfere with the ability to perform adequate oral hygiene or the capability of providing written informed consent and compliance with the protocol
  • Any disorder that would interfere with wound healing or represent a contraindication for implant surgery, such as but not limited to uncontrolled diabetes or conditions resulting in or requiring immunosuppression, radiation, chemotherapy, frequent use of antibiotics or antiresorptive medication such as bisphosphonates.
  • Pregnancy or lactation
  • Heavy smoking habit with ≥ 10 cig/d
  • Severe bruxism or clenching habits, presence of oro-facial pain
  • Insufficient ridge width/height for the study implant

Arms & Interventions

Test

Dual-cantilevered single implant bridge

Intervention: Dual-cantilevered implant bridge

Control

3-unit implant fixed dental prosthesis

Intervention: 3-unit iFDP

Outcomes

Primary Outcomes

Implant and prosthetic success

Time Frame: 10 years

Primary outcome parameter: implant and prosthetic success Implant success and survival rate will be defined according to established criteria (Buser et al. 1991): A surviving implant and/or restoration is defined as are in place at the time of the follow-up.

Implant and prosthetic survival

Time Frame: 10 years

Implant success and survival rate will be defined according to established criteria (Buser et al. 1991): A surviving implant and/or restoration is defined as are in place at the time of the follow-up.

Secondary Outcomes

  • Implant and prosthetic complications(10 years)

Study Sites (1)

Loading locations...

Similar Trials